SG11202102204PA - Process of making calcium alpha-ketoglutarate - Google Patents

Process of making calcium alpha-ketoglutarate

Info

Publication number
SG11202102204PA
SG11202102204PA SG11202102204PA SG11202102204PA SG11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA SG 11202102204P A SG11202102204P A SG 11202102204PA
Authority
SG
Singapore
Prior art keywords
ketoglutarate
making calcium
calcium alpha
alpha
making
Prior art date
Application number
SG11202102204PA
Inventor
David Eugene Pereira
Keshav Deo
Original Assignee
Ponce De Leon Health Designated Activity Company
David Eugene Pereira
Keshav Deo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponce De Leon Health Designated Activity Company, David Eugene Pereira, Keshav Deo filed Critical Ponce De Leon Health Designated Activity Company
Publication of SG11202102204PA publication Critical patent/SG11202102204PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/418—Preparation of metal complexes containing carboxylic acid moieties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/347—Saturated compounds containing more than one carboxyl group containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11202102204PA 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate SG11202102204PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862736320P 2018-09-25 2018-09-25
PCT/US2019/052498 WO2020068705A1 (en) 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate

Publications (1)

Publication Number Publication Date
SG11202102204PA true SG11202102204PA (en) 2021-04-29

Family

ID=69952136

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202102204PA SG11202102204PA (en) 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate

Country Status (17)

Country Link
US (1) US11802103B2 (en)
EP (1) EP3856166A4 (en)
JP (1) JP7499259B2 (en)
KR (1) KR20210065120A (en)
CN (1) CN112955139A (en)
AU (1) AU2019350699B2 (en)
BR (1) BR112021005668A2 (en)
CA (1) CA3112205A1 (en)
CL (1) CL2021000728A1 (en)
CO (1) CO2021004529A2 (en)
IL (1) IL281761A (en)
MX (1) MX2021003482A (en)
PE (1) PE20211816A1 (en)
PH (1) PH12021550403A1 (en)
SG (1) SG11202102204PA (en)
TW (1) TW202024013A (en)
WO (1) WO2020068705A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020068705A1 (en) 2018-09-25 2020-04-02 Ponce De Leon Health Designated Activity Company Process of making calcium alpha-ketoglutarate
CN112941116B (en) * 2021-01-04 2022-12-02 上海朴颐化学科技有限公司 Method for preparing alpha-ketoglutarate calcium by enzyme method
CN114105761B (en) * 2021-11-19 2024-06-21 广东派特埃尔生物科技有限公司 Synthesis process of alpha-ketoglutarate sodium salt

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776926A (en) 1955-08-04 1957-01-08 Eugene S Sharpe Preparation of alpha-ketoglutaric acid by serratia marcescens
US2917528A (en) * 1956-08-24 1959-12-15 Victor Chemical Works Alkanolaminealkanephosphonic acids and salts thereof
US2841616A (en) * 1956-10-30 1958-07-01 Campbell Soup Co Process for the recovery of alpha-ketoglutaric acid
US3875304A (en) 1970-04-24 1975-04-01 Schlitz Brewing Co J Livestock feed composition and method of preparing the same
US4045585A (en) 1976-05-19 1977-08-30 Decel Corporation Flavored animal food compositions
DE3151196A1 (en) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer METHOD FOR PRODUCING EASILY SOLUBLE 5-AMINOSALICYL ACID MEDICAL PREPARATIONS
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5646187A (en) 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
US6306430B1 (en) 1998-04-16 2001-10-23 The Iams Company Process for decreasing adiposity using vitamin a as a dietary supplement
US6905707B2 (en) 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
CO5140079A1 (en) 1998-10-14 2002-03-22 Novartis Ag PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERATION AND METHOD TO RELEASE A PHARMACEUTICALLY ACTIVE AGENT FROM SUSTAINED LIBERATION AND METHOD TO RELEASE A PHARMACEUTICALLY ACTIVE AGENT
US6649654B1 (en) 1999-11-23 2003-11-18 The Regents Of The University Of California Methods for identifying and using IKK inhibitors
JP4169596B2 (en) 2000-12-20 2008-10-22 アルコン、インコーポレイテッド Solution for removing cataracts by liquefaction destruction
EP1622629B1 (en) * 2003-05-07 2013-07-10 Osteologix A/S Controlled-release composition containing a strontium salt
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
PL368572A1 (en) 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
CA2574597A1 (en) 2004-08-09 2006-02-16 Cancer Research Technology Limited Alpha-ketoglutarates and their use as therapeutic agents
DK1824470T3 (en) 2004-12-17 2014-08-18 Cash Alan Brian PROCEDURE FOR EXTENDING LIFE AND DELAYING THE TIME OF AGE FOR AGE-RELATED DISEASE
US20060234250A1 (en) 2005-04-15 2006-10-19 Powers Ralph W Iii Methods of screening and compositions for life span modulators
WO2007001883A2 (en) 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
CA2628265A1 (en) 2005-11-08 2007-05-18 Multi Formulations Ltd. The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance
US8367121B2 (en) 2005-11-23 2013-02-05 Florida A & M University Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
PL379512A1 (en) 2006-04-21 2007-10-29 Sgp & Sons Ab New methods and their application
PL226695B1 (en) 2006-07-03 2017-08-31 Danuta Kruszewska Agent for preventing and/or inhibiting the colonization of Helicobater pylori and its application
WO2008115783A1 (en) 2007-03-19 2008-09-25 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
KR20100039874A (en) 2007-07-02 2010-04-16 엔트레스 에이비 New use of known pharmacologically active chemical compounds
EP2033623A1 (en) 2007-09-07 2009-03-11 Cutech S.R.L. Compositions comprising ornithine ketoglutarate (OKG)
JP5406643B2 (en) * 2008-09-22 2014-02-05 日本合成化学工業株式会社 Method for producing metal salt of α-oxocarboxylic acid
CN101759553A (en) 2008-11-21 2010-06-30 扬子江药业集团北京海燕药业有限公司 Method for preparing alpha-calcium picrolonate
DE102009016119A1 (en) 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nutritional supplement containing alpha-keto acids to support diabetes therapy
EP2416792A4 (en) 2009-04-10 2012-10-24 Haiyan Qi Novel anti-aging agents and methods to identify them
SG175994A1 (en) 2009-05-11 2011-12-29 Berg Biosystems Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
EP2434908A2 (en) 2009-05-28 2012-04-04 The IAMS Company Pet food in the form of a coated kibble
AU2010258354B2 (en) 2009-06-12 2015-08-13 Generex Pharmaceuticals, Inc. Composition used to prevent and treat red blood cell coagulation
CN105534978A (en) 2009-06-30 2016-05-04 德安生医有限公司 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders
WO2011060305A1 (en) 2009-11-12 2011-05-19 Nox Technologies, Inc. Potato skin compositions that lower cytosolic nadh level to mimic calorie restriction
US20140065099A1 (en) 2011-02-15 2014-03-06 Ecole Polytechnique Federale De Lausanne (Epfl) Methods of Treating Mitochondrial Dysfunction
RU2013151083A (en) 2011-04-18 2015-05-27 Нестек С.А. NUTRITIONAL COMPOSITIONS CONTAINING α-HYDROXYSIOCOPRONIC ACID (α-HICA) AND CITRULLIN, AND WAYS OF THEIR APPLICATION
US9248185B2 (en) 2011-06-16 2016-02-02 President And Fellows Of Harvard College Methods of increasing satellite cell proliferation
CN102586347B (en) * 2012-03-06 2014-04-09 江南大学 Two-stage pH (Potential Of Hydrogen) control method for high output of alpha-ketoglutaric acid
WO2013152120A2 (en) 2012-04-03 2013-10-10 Whitehead Institute For Biomedical Research Compositions and methods for promoting intestinal stem cell function
ITBO20120226A1 (en) 2012-04-24 2013-10-25 Alfa Wassermann Spa COMPOSITIONS INCLUDING ALPINE-KETOGLUTARATE ORNITINE, PROCESSES FOR THEIR ACHIEVEMENT AND THEIR USE.
JP6029058B2 (en) * 2012-09-14 2016-11-24 国立研究開発法人農業・食品産業技術総合研究機構 Ice nucleator containing calcium oxalate
ES2681343T3 (en) 2012-09-19 2018-09-12 Grespo Ab Compositions for the improvement of brain function
CN102976927A (en) * 2012-12-26 2013-03-20 天津天成制药有限公司 Preparation method of calcium alpha-ketoglutarate
CA2896646A1 (en) 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Skin-exterior anti-ageing composition and production method therefor
WO2014116985A1 (en) 2013-01-25 2014-07-31 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
US9511057B2 (en) 2013-03-15 2016-12-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating denervation-induced muscle atrophy
CA2902603C (en) 2013-03-19 2021-03-02 University Of South Florida Compositions and methods for producing elevated and sustained ketosis
US20160263092A1 (en) 2013-12-19 2016-09-15 Twi Biotechnology, Inc. Therapeutic uses of berberine formulations
US20160354334A1 (en) 2014-02-12 2016-12-08 The Regents Of The University Of California Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms
US10258639B2 (en) 2014-05-06 2019-04-16 Research Development Foundation Methods for treating insulin resistance and for sensitizing patients to GLP1 agonist therapy
JP2017520553A (en) 2014-06-30 2017-07-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ketobutyric acid compounds and compositions for treating age-related symptoms and diseases
CA3194562A1 (en) 2014-07-29 2016-02-04 Shenzhen Hightide Biopharmaceutical, Ltd. Berberine-ursodeoxycholic salt, method of preparation and application therof
US20170266253A1 (en) 2014-07-31 2017-09-21 Indiana University Research And Technology Corporation Antithetical regulation of endothelial ace and ace2 by brg1-foxm1 complex underlies pathological cardiac hypertrophy
CN104529755B (en) * 2014-12-29 2016-01-06 精晶药业股份有限公司 A kind of method being separated α-ketoglutaric acid from conversion fluid
JP2018517666A (en) 2015-04-06 2018-07-05 シンセン ハイタイド バイオファーマシューティカル リミテッド Ursodeoxycholic acid, berberine or L-carnitine conjugate compounds, and compositions and methods thereof
RU2017145692A (en) 2015-06-10 2019-07-10 Элизиум Хелт, Инк. COMPOSITIONS OF NICOTINAMIDE RIBOSIDE AND PTEROSTYLBENE AND METHODS OF TREATING DISEASES OF THE SKIN
US20180193458A1 (en) 2015-07-08 2018-07-12 Unity Biotechnology, Inc. Compositions and methods for treating senescence-associated diseases and disorders
EP3518915A4 (en) 2016-09-30 2020-04-15 The Regents of the University of California Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth
PL231635B1 (en) 2017-01-03 2019-03-29 Politechnika Poznanska Method for production of alpha-ketoglutaric acid (AKG) from one-component water solutions
MX2017004010A (en) 2017-03-27 2018-02-09 Antonio Hernandez Miramontes Jorge A mixture of oxalacetate, alpha-ketoglutarate, tartaric acid and salts of calcium and sodium lactate, for treating patients with chronic renal insufficiency.
KR20230167450A (en) 2017-04-25 2023-12-08 버크 인스티튜트 포 리서치 온 에이징 Formulations for extending lifespan and healthspan
WO2019038655A1 (en) 2017-08-21 2019-02-28 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
WO2020068705A1 (en) 2018-09-25 2020-04-02 Ponce De Leon Health Designated Activity Company Process of making calcium alpha-ketoglutarate
EP3870184A4 (en) 2018-10-24 2022-07-20 Ponce de Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension
AU2020293094A1 (en) 2019-06-10 2022-01-06 Buck Institute For Research On Aging Methods and compositions for altering senescence associated secretory phenotype
JP2022537685A (en) * 2019-06-10 2022-08-29 ポンス デ レオン ヘルス デジクネイテッド アクティビティ カンパニー Sustained-release compositions of alpha-ketoglutarate
WO2022006500A1 (en) 2020-07-02 2022-01-06 Ponce De Leon Health Designated Activity Company Compositions and methods for treating crp-mediated diseases
CN115974679A (en) * 2022-12-20 2023-04-18 绍兴市精益生物化工有限公司 Preparation method of alpha-ketoglutarate calcium salt

Also Published As

Publication number Publication date
PH12021550403A1 (en) 2021-10-04
AU2019350699B2 (en) 2024-05-23
MX2021003482A (en) 2021-06-18
US20210371368A1 (en) 2021-12-02
TW202024013A (en) 2020-07-01
EP3856166A1 (en) 2021-08-04
AU2019350699A1 (en) 2021-04-08
CL2021000728A1 (en) 2021-10-22
WO2020068705A1 (en) 2020-04-02
PE20211816A1 (en) 2021-09-14
CA3112205A1 (en) 2020-04-02
US11802103B2 (en) 2023-10-31
CN112955139A (en) 2021-06-11
JP2022502489A (en) 2022-01-11
IL281761A (en) 2021-05-31
JP7499259B2 (en) 2024-06-13
BR112021005668A2 (en) 2021-06-22
CO2021004529A2 (en) 2021-04-30
EP3856166A4 (en) 2022-06-22
KR20210065120A (en) 2021-06-03

Similar Documents

Publication Publication Date Title
IL281761A (en) Process of making calcium alpha-ketoglutarate
ZA202004497B (en) Process of making somatostatin modulators
SI3630738T1 (en) Process for the production of ozanimod
GB201806072D0 (en) Methods of manufacture
ZA202105072B (en) Production line of ca abrasive
PT3487812T (en) Production of amorphous calcium carbonate
GB201804594D0 (en) Bonegraft substituteand method of manufacture
GB201802839D0 (en) Method of manufacture
PL3755681T3 (en) Method of 4-boronophenylalanine production
GB201805904D0 (en) Methods of Manufacture
PL3856700T3 (en) Method of producing a carbon-ceramic shaped body
GB201814291D0 (en) Process for the production of gallium radionculides
HUE057578T2 (en) Process for the treatment of wastewater formed during the production of modified starches
NO20170008A1 (en) A process for treatment of fly ash
IL281378A (en) Method for improved production of isomalt
ZA202101670B (en) Process for the production of syngas
HUP1800125A2 (en) Process for production of iloprost
PT3759082T (en) Process for the synthesis of 6-chloromethyluracil
PL3609842T3 (en) Method for production of precipitated calcium carbonate (pcc)
ZA201801284B (en) Production of form coke
IL256062B (en) Process for treating of threads
EP3974411C0 (en) Process of preparing diazomethane
HUE063678T2 (en) Process for the production of peroxyesters
HUP1800088A2 (en) Process for antigradation of starch
PH22018050090U1 (en) Process of making fish polvoron